Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 4
2003 5
2004 1
2005 4
2006 4
2007 3
2008 4
2009 3
2010 2
2011 3
2012 5
2013 4
2014 5
2015 10
2016 13
2017 11
2018 12
2019 10
2020 14
2021 15
2022 9
2023 10
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
Teprotumumab for the Treatment of Active Thyroid Eye Disease.
Douglas RS, Kahaly GJ, Patel A, Sile S, Thompson EHZ, Perdok R, Fleming JC, Fowler BT, Marcocci C, Marinò M, Antonelli A, Dailey R, Harris GJ, Eckstein A, Schiffman J, Tang R, Nelson C, Salvi M, Wester S, Sherman JW, Vescio T, Holt RJ, Smith TJ. Douglas RS, et al. Among authors: marino m. N Engl J Med. 2020 Jan 23;382(4):341-352. doi: 10.1056/NEJMoa1910434. N Engl J Med. 2020. PMID: 31971679 Clinical Trial.
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study.
Douglas RS, Kahaly GJ, Ugradar S, Elflein H, Ponto KA, Fowler BT, Dailey R, Harris GJ, Schiffman J, Tang R, Wester S, Jain AP, Marcocci C, Marinò M, Antonelli A, Eckstein A, Führer-Sakel D, Salvi M, Sile S, Francis-Sedlak M, Holt RJ, Smith TJ. Douglas RS, et al. Among authors: marino m. Ophthalmology. 2022 Apr;129(4):438-449. doi: 10.1016/j.ophtha.2021.10.017. Epub 2021 Oct 21. Ophthalmology. 2022. PMID: 34688699 Free article. Clinical Trial.
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves' Disease Hyperthyroidism During Methimazole Treatment.
Gallo D, Mortara L, Veronesi G, Cattaneo SA, Genoni A, Gallazzi M, Peruzzo C, Lasalvia P, Moretto P, Bruno A, Passi A, Pini A, Nauti A, Lavizzari MA, Marinò M, Lanzolla G, Tanda ML, Bartalena L, Piantanida E. Gallo D, et al. Among authors: marino m. Front Endocrinol (Lausanne). 2022 Jun 15;13:886451. doi: 10.3389/fendo.2022.886451. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35784564 Free PMC article. Clinical Trial.
Antioxidant Therapy in Graves' Orbitopathy.
Lanzolla G, Marcocci C, Marinò M. Lanzolla G, et al. Among authors: marino m. Front Endocrinol (Lausanne). 2020 Dec 14;11:608733. doi: 10.3389/fendo.2020.608733. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33381085 Free PMC article. Review.
Statins in Graves Orbitopathy: A New Therapeutic Tool.
Lanzolla G, Comi S, Cosentino G, Pakdel F, Marinò M. Lanzolla G, et al. Among authors: marino m. Ophthalmic Plast Reconstr Surg. 2023 Dec 1;39(6S):S29-S39. doi: 10.1097/IOP.0000000000002525. Epub 2023 Dec 4. Ophthalmic Plast Reconstr Surg. 2023. PMID: 38054983 Review.
Statins: A New Hope on the Horizon of Graves Orbitopathy?
Marinò M, Lanzolla G, Marcocci C. Marinò M, et al. J Clin Endocrinol Metab. 2021 Jun 16;106(7):e2819-e2821. doi: 10.1210/clinem/dgab184. J Clin Endocrinol Metab. 2021. PMID: 33735381 No abstract available.
Selenium in Graves Hyperthyroidism and Orbitopathy.
Marinò M, Menconi F, Rotondo Dottore G, Leo M, Marcocci C. Marinò M, et al. Ophthalmic Plast Reconstr Surg. 2018 Jul/Aug;34(4S Suppl 1):S105-S110. doi: 10.1097/IOP.0000000000001136. Ophthalmic Plast Reconstr Surg. 2018. PMID: 29933354 Review.
139 results